HIV and women in the USA: what we know and where to go from here

被引:49
|
作者
Adimora, Adaora A. [1 ,3 ,4 ]
Ramirez, Catalina [1 ]
Poteat, Tonia [2 ]
Archin, Nancie M. [1 ]
Averitt, Dawn [4 ]
Auerbach, Judith D. [4 ,5 ]
Agwu, Allison L. [6 ,7 ]
Currier, Judith [8 ]
Gandhi, Monica [5 ]
机构
[1] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
[4] Well Project, Res Initiat HIV AIDS, New York, NY USA
[5] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA
[6] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA
关键词
UNITED-STATES; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; TRANSGENDER WOMEN; FELON DISFRANCHISEMENT; SEX-DIFFERENCES; INFECTED WOMEN; BLACK-WOMEN; DISPARITIES; PREVALENCE;
D O I
10.1016/S0140-6736(21)00396-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New diagnoses of HIV infection have decreased among women in the USA overall, but marked racial and geographical disparities persist. The federal government has announced an initiative that aims to decrease the number of new infections in the nation by 90% within the next 10 years. With this in mind, we highlight important recent developments concerning HIV epidemiology, comorbidities, treatment, and prevention among women in the USA. We conclude that, to end the US HIV epidemic, substantially greater inclusion of US women in clinical research will be required, as will better prevention and treatment efforts, with universal access to health care and other supportive services that enable women to exercise agency in their own HIV prevention and care. Ending the epidemic will also require eliminating the race, class, and gender inequities, as well as the discrimination and structural violence, that have promoted and maintained the distribution of HIV in the USA, and that will, if unchecked, continue to fuel the epidemic in the future.
引用
收藏
页码:1107 / 1115
页数:9
相关论文
共 50 条
  • [31] Glaucoma in Black Individuals: How Far Have We Come and Where Do We Go From Here?
    Kitayama, Ken
    Wilson, M. Roy
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 259 : 96 - 101
  • [32] IBD-related mental health disorders: where do we go from here?
    Gomez, David Augusto
    Ahmad-Waqar, Muhammad
    Brookes, Matthew James
    Kumar, Aditi
    FRONTLINE GASTROENTEROLOGY, 2023, 14 (06) : 512 - 520
  • [33] Obesity Is Associated With Structural and Functional Brain Abnormalities: Where Do We Go From Here?
    Convit, Antonio
    PSYCHOSOMATIC MEDICINE, 2012, 74 (07): : 673 - 674
  • [34] Race, ethnicity, and assisted reproductive technology outcomes: where do we go from here?
    Diego, Daniela
    Kawwass, Jennifer F.
    FERTILITY AND STERILITY, 2024, 122 (06) : 1010 - 1011
  • [35] Where do we go from here? Reconciling implementation failure of PrEP for Black women in the South. Leveraging critical realism to identify unaddressed barriers as we move forward
    Irie, Whitney C.
    Mahone, Anais
    Heffron, Renee
    Elopre, Latesha
    FRONTIERS IN REPRODUCTIVE HEALTH, 2024, 6
  • [36] What do we know about why women bleed and what do we not know?
    James, Andra H.
    James, Paula D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (02) : 315 - 322
  • [37] The Current State of Knowledge on the Industrial Epidemiologic Transition: Where Do We Go from Here?
    Gage, Timothy B.
    MODERN ENVIRONMENTS AND HUMAN HEALTH: REVISITING THE SECOND EPIDEMIOLOGIC TRANSITION, 2014, : 377 - 392
  • [38] Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don't We Know?
    Baeten, Jared M.
    Grant, Robert
    CURRENT HIV/AIDS REPORTS, 2013, 10 (02) : 142 - 151
  • [39] Primary Aldosteronism: Where Are We Now? Where to From Here?
    Funder, John W.
    Carey, Robert M.
    HYPERTENSION, 2022, 79 (04) : 726 - 735
  • [40] Primary Aldosteronism: Where Are We Now? Where to from Here?
    Funder, John Watson
    HORMONE AND METABOLIC RESEARCH, 2020, 52 (06) : 459 - 466